1034467-27-0

Basic information

• Product Name: 2-fluoro-4-iodo-5-(MethoxyMethoxy)pyridine
• Synonyms: 2-fluoro-4-iodo-5-(MethoxyMethoxy)pyridine
• CAS NO: 1034467-27-0
• Molecular Formula: C7H7FINO2
• Molecular Weight: 283.0388532
• Mol File: 1034467-27-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 2-fluoro-4-iodo-5-(MethoxyMethoxy)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-fluoro-4-iodo-5-(MethoxyMethoxy)pyridine(1034467-27-0)
• EPA Substance Registry System: 2-fluoro-4-iodo-5-(MethoxyMethoxy)pyridine(1034467-27-0)

Safety Data

• Hazardous Substances Data: 1034467-27-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Synthesis:
2-fluoro-4-iodo-5-(methoxymethoxy)pyridine is used as a key intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of biologically active molecules. Its unique structure allows for the creation of new drugs with potential therapeutic applications.
Used in Agrochemical Development:
In the agrochemical industry, 2-fluoro-4-iodo-5-(methoxymethoxy)pyridine serves as a building block for the synthesis of novel agrochemicals, potentially leading to the discovery of new pesticides or herbicides with improved efficacy and selectivity.
Used in Material Science:
2-fluoro-4-iodo-5-(methoxymethoxy)pyridine is utilized in the development of new materials due to its chemical properties, which may contribute to the creation of advanced materials with specific characteristics for various applications.
Used as a Reagent in Organic Chemistry:
2-fluoro-4-iodo-5-(methoxymethoxy)pyridine also functions as a reagent in organic chemistry reactions, facilitating specific transformations and syntheses that are otherwise challenging to achieve, thus expanding the scope of organic synthesis methodologies.

Upstream product

• 1034467-25-8 2-fluoro-5-(methoxymethoxy)pyridine 
• 55758-32-2 6-fluoropyridin-3-ol 

Relevant articles and documents

SUBSTITUTED TRIAZINONES AS THYROID HORMONE RECEPTOR AGONISTS

The application relates to a compound of Formula (I') or (I), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of thyroid hormone receptors, a pharmaceutical composition comprising a compound of Formula (I') or (I), and a method of treating or preventing a disease or disorder regulated by thyroid hormone.

TRIAZOLYL AMINOPYRIMIDINE COMPOUNDS

The present invention provides triazolyl aminopyrimidine compounds useful in the treatment of cancer.

IMIDAZOLIDINONYL AMINOPYRIMIDINE COMPOUNDS FOR THE TREATMENT OF CANCER

The present invention provides novel imidazolidinonyl aminopyrimidine compounds believed to have clinical use for treatment of cancer through inhibiting Plk1. Formula I wherein: R1 is aminomethyl, (C1-C3 alkyl)aminomethyl, di(C1-C2 alkyl)aminomethyl, N- ethyl-N-methyl-aminomethyl, 1-aminoethyl, 1-((C1-C2 alkyl)amino)-ethyl, 3,3,3- trifluoropropylaminomethyl, ethynyl, 2-hydroxy-ethoxy, 2-hydroxyethylaminomethyl, 2- cyanoethylaminomethyl, mopholin-4-ylmethyl, methoxymethoxymethyl, cyclopropyl, 1- azetidinylmethyl, 1-pyrrolidinylmethyl, or 1,3-dioxolan-2-yl; R2 is hydrogen or halo; R3 is hydrogen or halo; provided that at least one of R2 and R3 is hydrogen; R4 is hydrogen, methyl, or halo; and is a single bond that is either present or absent, or a pharmaceutically acceptable salt thereof.

IMIDAZOLIDINONYL AMINOPYRIMIDINE COMPOUNDS FOR THE TREATMENT' OF CANCER

The present invention provides novel imidazolidinonyl aminopyrimidine compounds believed to have clinical use for treatment of cancer through inhibiting Plk1. wherein: R1 hydrogen, hydroxy, halo, methyl, C1-C2 alkoxy, amino, or rnethylamino; R2 is hydrogen, halo, or cyano; R3 is hydrogen or halo;, R4 is hydrogen, halo, or methyl; provided that at least two of R1, R2, R3, and R4 are hydrogen; R5 is hydrogen, halo, or methyl; or a pharmaceutically acceptable salt thereof.